Winthrop P. Rockefeller Cancer Institute
May 9, 2025
UAMS Invests Rangaswamy Govindarajan, M.D., MRCP, in Hutchins Distinguished Chair for Hematology and Oncology
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) College of Medicine invested Rangaswamy Govindarajan, M.D., MRCP, a professor in the UAMS College of Medicine and director of the Division of Hematology and Oncology in the UAMS Department of Internal Medicine, in the Laura F. Hutchins, M.D., Distinguished Chair for Hematology and Oncology…
April 22, 2025
UAMS Winthrop P. Rockefeller Cancer Institute Scientists Uncover New Opportunities for Targeted Cancer Therapies
Molecular Cell publishes UAMS comprehensive structural biology study of MCL-1:BAK complex found in most cancers A research team led by UAMS Winthrop P. Rockefeller Cancer Institute scientist, Tudor Moldoveanu, Ph.D., has uncovered novel insights into one of the body’s most fundamental processes impacting the development of cancer. Known as apoptosis, the research on the process…
April 7, 2025
UAMS Winthrop P. Rockefeller Cancer, Rison Pharmacy Partner to Host Colon Cancer Screening Event April 17
Residents of Cleveland County are invited to a colon cancer screening event on Thursday, April 17, in Rison. Patient navigators from the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) will offer free take-home colorectal cancer screening kits, as well as information and resources on other recommended cancer screenings….
Looking Toward the Future: Myeloma Center Celebrates 35th Anniversary
The Myeloma Center, located in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), has firmly established itself as an international leader in myeloma treatment. From its beginnings in 1989, UAMS’ myeloma program is recognized for detailed patient care, groundbreaking research and pioneering advances in the management of myeloma…
April 3, 2025
UAMS Winthrop P. Rockefeller Cancer Institute Hosts Fifth ‘Be A Part of the Cure’ Walk on May 3
The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) will hold its fifth Be A Part of the Cure Walk to support cancer patients, survivors and families at 8 a.m., May 3, at War Memorial Stadium in Little Rock. Gates open at 6:30 a.m.
March 31, 2025
NIH Awards UAMS Nearly $3 Million to Study DNA Structures that Could Impact Cancer Treatment
LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) researcher Kevin Raney, Ph.D., has been awarded a five-year, $2.99 million grant from the National Institutes of Health (NIH) to study unusual DNA structures called quadruplexes, which may act like natural drugs by binding to key proteins involved in disease. The grant from the NIH…
March 28, 2025
24-Year Myeloma Survivor Cites Positive Attitude as Key to Longevity
Jeff Williams maintains a basic approach to living with multiple myeloma. “Get as much exercise as possible,” he said. “I work about a mile from a YMCA. I stay in shape. It has to be a habit. If you go long enough, it will become a habit. Resistance training builds bone density.” Williams, 66, is…
March 19, 2025
UAMS Invests Fenghuang “Frank” Zhan, M.D., Ph.D., in Inaugural Barlogie Chair for Myeloma Research
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) College of Medicine invested Fenghuang “Frank” Zhan, M.D., Ph.D., a tenured professor of medicine and the research director of the UAMS Winthrop P. Rockefeller Cancer Institute’s Myeloma Center, in the Dr. Bart Barlogie Chair for Myeloma Research during a March 13 ceremony. Zhan is…
March 14, 2025
Behind the Scenes
Visanu Wanchai, Ph.D. Visanu Wanchai, Ph.D., is a postdoctoral fellow with the UAMS College of Medicine. He earned his doctorate in biomedical informatics from UAMS in 2020 and joined the Myeloma Center in 2022. His focus is developing leading-edge computational tools and employing high-performance computing techniques for single cell analysis to investigate key genes and…
Publications
Bispecific BCMA/CD24 CAR T cells control multiple myeloma growth Nature Communications January 2024 Primary authors: Fumou Sun, Ph.D.; Yan Cheng, Ph.D. Anti-multiple myeloma B cell maturation antigen (BCMA)-specific chimeric antigen receptor (CAR) T-cell therapies represent a promising treatment strategy with high response rates in myeloma. However, durable cures following anti-BCMA CAR T-cell treatment of myeloma…
Previous page Next page